Edwards Lifesciences Corp
EW- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001099800
In the last 90 days, Edwards Lifesciences Corp insiders filed 0 open-market purchases and 10 sales; 1,344 institutions reported holding it in 13F filings for Q2 2026, worth $47.2B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Edwards Lifesciences Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 10 filings
- 6 insiders, $4.54M in total
- Insiders trading
- 6
- Net value
- −$4.54M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Edwards Lifesciences Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Markowitz Wayne | CVP, JAPAC | 19,371 | Sep 14, 2026 | 6 |
| Dahl Andrew M. | SVP, Corporate Controller | 14,615 | Sep 14, 2026 | 6 |
| Chopra Daveen | CVP, TMTT, Surgical & IHFM | 43,926 | Sep 11, 2026 | 7 |
| Lippis Daniel J. | CVP, TAVR | 40,034 | Sep 11, 2026 | 16 |
| Bruls Annette | CVP, EMEACLA | 17,984 | Aug 28, 2026 | 3 |
| Zovighian Bernard J | CEO | 8,916Indirect | Jul 27, 2026 | 7 |
| Mistras Theodora | CVP, Chief Financial Officer | 99,920 | Jul 10, 2026 | 1 |
| Bobo Donald E Jr | CVP,Strategy/Corp Development | 98,611Indirect | May 27, 2026 | 11 |
| Ullem Scott B. | CVP, Chief Financial Officer | 46,740 | May 11, 2026 | 8 |
| Laviolette Paul A | Director | 17,552 | May 8, 2026 | 1 |
| Loranger Steven R | Director | 8,997 | May 8, 2026 | 1 |
| Stone Heisz Leslie | Director | 34,199 | May 8, 2026 | 2 |
| Valeriani Nicholas J | Director | 84,423 | May 8, 2026 | 1 |
| Gallahue Kieran | Director | 4,315 | May 8, 2026 | 1 |
| Feinberg David T | Director | 9,087 | May 8, 2026 | 1 |
| Sequeira Ramona | Director | 6,779 | May 8, 2026 | 1 |
| Davis Leslie C. | Director | 9,834 | May 8, 2026 | 1 |
| Wood Larry L | Global President TAVR & Surg | 206,900 | Aug 18, 2025 | 0 |
| Szyman Catherine M. | CVP, Critical Care | 81,287 | Sep 3, 2024 | 0 |
| Lemercier Jean-Luc M | CVP, EMEACLA and JAPAC | 184,686 | Jul 8, 2024 | 0 |
| Sellers Robert W.A. | SVP, Corporate Controller | 17,081 | May 13, 2024 | 0 |
| Mussallem Michael A | Director | 4,486 | May 2, 2024 | 0 |
| Marsh Martha H. | Director | 31,880 | May 15, 2023 | 0 |
| Wang Huimin | CVP, Japan & Intercontinental | 99,381 | Jul 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 (view filing) | May 29 | Same day | Dahl Andrew M.SVP, Corporate Controller | SSale | −567.53 | $86.08 | −$48.9K | −3.6%15.3K after | |
| Jun 17, 2026 (view filing) | Jun 17 | Same day | Zovighian Bernard JCEO | SSale | −523 | $87.92 | −$46.0K | −4.3%11.5K after | 10b5-1 |
| Jun 30, 2026 (view filing) | Jun 30 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $91.40 | −$56.6K | −1.5%40.4K after | 10b5-1 |
| Jul 10, 2026 (view filing)5:04 PM ET | Jul 10 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $91.70 | −$56.8K | −1.5%40.0K after | 10b5-1 |
| Jul 27, 2026 (view filing)6:59 PM ET | Jul 27 | Same day | Zovighian Bernard JCEO | SSale | −2.92K | $83.93 | −$245.1K | −24.7%8.92K after | |
| Jul 28, 2026 (view filing)7:40 PM ET | Jul 28 | Same day | Markowitz WayneCVP, JAPAC | SSale | −9.63K | $85.06 | −$819.0K | −30.8%21.7K after | |
| Jul 30, 2026 (view filing)5:30 PM ET | Jul 30 | Same day | Markowitz WayneCVP, JAPAC | SSale | −146.31 | $86.03 | −$12.6K | −0.7%21.5K after | |
| Aug 11, 2026 (view filing)5:07 PM ET | Aug 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $92.03 | −$57.0K | −1.5%40.0K after | 10b5-1 |
| Aug 26, 2026 (view filing)6:00 PM ET | Aug 26 | Same day | Markowitz WayneCVP, JAPAC | SSale | −1.24K | $91.47 | −$113.4K | −5.8%20.3K after | |
| Aug 26, 2026 (view filing)6:36 PM ET | Aug 26 | Same day | Chopra DaveenCVP, TMTT, Surgical & IHFM | SSale | −31.8K | $91.02 | −$2.89M | −41.8%44.3K after | 2 lots |
| Aug 28, 2026 (view filing)4:32 PM ET | Aug 28 | Same day | Bruls AnnetteCVP, EMEACLA | SSale | −2.64K | $89.98 | −$237.9K | −12.8%18.0K after | |
| Aug 31, 2026 (view filing)5:47 PM ET | Aug 31 | Same day | Dahl Andrew M.SVP, Corporate Controller | SSale | −544 | $91.06 | −$49.5K | −3.5%14.9K after | |
| Sep 11, 2026 (view filing)7:15 PM ET | Sep 11 | Same day | Lippis Daniel J.CVP, TAVR | SSale | −619 | $87.51 | −$54.2K | −1.5%40.0K after | 10b5-1 |